Report Detail
Women's Health: Benign Uterine Conditions Therapy Systems Market, November 2016
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunites in the benign uterine condition therapy systems market, including global endometrial ablation systems, MR-guided focused ultrasound systems, uterine artery embolization systems, and hysteroscopes/fibroid removal systems. The combined global market for these systems totaled nearly $1.3bn in 2015, and is expected to grow at a CAGR of 4.7% through 2020.